| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
P3 Health Partners Inc. Common Stock
$12.83
+4.67 (+40.33%)
Market Cap
42.67 M
EPS
-37.96
P/E Ratio
-
Value Trade
3.04 M
SEC Financials
Q1 2026Dilution Risk
Revenue
386.39 M
Operating CF
-27.47 M
Total Assets
674.16 M
Total Liabilities
807.32 M
Equity
-143.55 M
28.04 %
Week
22.54 %
1 Month
239.42 %
3 Month
401.17 %
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
26.10 M
Monthly Burn
9.16 M
Runway
0.2 mo
Burn Trend
SEC Filing
May 14, 2026
Overview
Volume
529.91 K
52 Week Range
1.52 - 16.89
% held by Insiders
56.91 %
% held by Institutions
6.83 %
Enterprise Value
379.01 M
Total Shares
3.33 M
Short %
2.68 %
Float Shares
1.19 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in PIII
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
PIII Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-PIII
Aug 10, 2026▲ +40.3%today
P3 Health Partners Announces Second Quarter 2026 Results
P3 Health Partners Inc. announced its financial results for Q2 2026, reporting an adjusted EBITDA of $54 million. The company highlighted that its core business is driving improved profitability and that it is executing its business plan effectively. These results indicate a positive trend in the company's financial performance.
Read more →-PIII
Jul 21, 2026P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call
P3 Health Partners Inc. has announced the release date for its financial results for the second quarter of 2026. The results will be made public on August 10, 2026, followed by a conference call at 1:30 PM PT/4:30 PM ET to discuss these results. This event reflects the company's ongoing commitment to transparency and investor relations.
Read more →-PIII
May 15, 2026▲ +180.1%on this news
Document EX 99.1 P3 HEALTH PARTNERS INC. and SUBSIDIARIES PRO FORMA CONDENSED CONSOLIDATED BALANCE SHEET (in thousands, except per share amounts) (unaudited)
P3 Health Partners Inc. released a pro forma condensed consolidated balance sheet reflecting significant changes. The total assets increased to $704,157, incorporating a $30,000 Series D preferred stock issuance. However, the total liabilities, despite a debt conversion, reflect a concerning level. The company's accumulated deficit remains notably high, raising questions about future financial stability.
Read more →-PIII
May 14, 2026▲ +12.9%on this news· ran to +216% by day 1shared move
P3 Health Partners Announces First Quarter 2026 Results
P3 Health Partners has announced its financial results for the first quarter of 2026. The article provides limited details, focusing primarily on the announcement itself without elaborating on specific financial metrics or performance indicators.
Read more →-PIII
Apr 16, 2026P3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference Call
P3 Health Partners has announced the scheduling of its earnings release for the first quarter of 2026, along with a conference call. This event is expected to provide insights into the company's financial performance and strategic direction. Further details regarding the time and access to the call will be shared closer to the date.
Read more →-PIII
Mar 26, 2026▼ -10.3%on this news
P3 Health Partners Announces Fourth Quarter and Full Year 2025 Results Providing 2026 Guidance, Indicating a $10 Million Adjusted EBITDA Midpoint Management to Host Conference Call and Webcast
P3 Health Partners Inc. has announced its financial results for Q4 and the full year of 2025, highlighting a significant net loss and a decline in at-risk membership. The company reported total revenue growth but also faced increased Adjusted EBITDA losses. Looking forward, P3 provided guidance for 2026 that anticipates considerable year-over-year improvements in EBITDA, alongside a path to potential profitability. Despite these challenges, management remains optimistic about strategic positioning and future growth prospects.
Read more →-PIII
Nov 14, 2025P3 Health Partners Announces Third Quarter 2025 Results P3 Reports Continued Operational Progress and Expansion of Care Enablement Model in a Transitional Year $120 to $170 Million EBITDA Expansion Opportunity Strengthen
P3 Health Partners announced its third quarter 2025 results, showcasing operational progress amidst financial challenges. The company's Care Enablement Model is seen as a pivotal factor driving positive momentum, with significant EBITDA expansion opportunities projected. However, the report also highlighted a 10% decline in average at-risk membership and a total revenue decrease of 5%, raising concerns about the overall financial health moving forward. The management remains optimistic about executing their growth strategies aiming for profitability in 2026.
Read more →-PIII
Aug 14, 2025P3 Health Partners Announces Second Quarter 2025 Results Core Business Demonstrates Strength with Flat Medical Cost Trends Despite Industry Inflation $120-$170 Million in Additional EBITDA Opportunities Identified for 20
P3 Health Partners reported its second quarter 2025 financial results, showcasing a resilient core business with flat medical cost trends despite industry challenges. The company has identified significant EBITDA opportunities ranging from $120 to $170 million for 2026. However, it also faced a 6% decline in total revenue and a 9% decrease in average at-risk membership compared to the prior year, leading to an Adjusted EBITDA loss. The management remains optimistic about the company's financial trajectory, supported by improved funding on a per-member basis.
Read more →-PIII
Jul 16, 2025The Difference Between Heat Stroke and Heat Exhaustion
The article discusses heat-related illnesses, specifically heat exhaustion and heat stroke, emphasizing their symptoms and prevention methods. It highlights the importance of recognizing signs of these conditions to avoid severe health risks. The article also outlines vulnerable populations and offers practical advice for staying cool and hydrated during extreme heat.
Read more →-PIII
May 15, 2025P3 Health Partners Announces First Quarter 2025 Results Affirming 2025 guidance Management to Host Conference Call and Webcast
P3 Health Partners has reported its financial results for the first quarter of 2025, affirming its 2025 guidance. The company saw a decrease in average at-risk membership by 8% compared to the previous year, and total revenue fell 4% year-over-year. Despite this, management highlights positive steps forward, including that three out of four markets reached breakeven or better during the quarter. However, Adjusted EBITDA losses expanded compared to the first quarter of the prior year. The management is committed to leveraging technology and enhancing care programs as part of their long-term strategic vision.
Read more →-PIII
Apr 15, 2025Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a common non-cancerous enlargement of the prostate gland in older men. It can cause urinary issues, particularly at night, affecting quality of life. While not dangerous, untreated BPH may lead to complications like urinary retention. Treatment options include lifestyle changes, medications, and minimally invasive procedures.
Read more →-PIII
Apr 15, 2025Urinary Incontinence
The article discusses urinary incontinence in seniors, highlighting its prevalence and impact on confidence and social life. It emphasizes that incontinence is not a normal part of aging and can often be treated with pelvic floor exercises, medications, or other therapies. Despite its commonality, many seniors do not discuss the issue with their doctors, even though effective treatments exist.
Read more →-PIII
Apr 15, 2025Hearing Loss
The article discusses age-related hearing loss, known as presbycusis, which primarily affects seniors. It highlights the gradual nature of this condition, particularly in high-pitched sounds, and its links to social isolation and cognitive decline. The piece emphasizes the importance of early treatment and the effectiveness of modern hearing aids in improving communication and overall health.
Read more →-PIII
Apr 15, 2025▲ +8.2%on this newsshared move
Vision Loss
The article discusses common age-related vision problems such as cataracts, glaucoma, and macular degeneration, which can lead to significant vision loss if untreated. It highlights the importance of early detection and regular eye exams for seniors, noting that over one-third of seniors experience vision issues. The article also touches on the risks associated with untreated vision problems.
Read more →-PIII
Apr 15, 2025▲ +9.4%on this newsshared move
Anxiety Disorders
The article discusses the impact of anxiety disorders on senior health, highlighting how persistent worry can interfere with daily life. It notes that anxiety often coexists with other conditions such as depression and dementia. The piece emphasizes the importance of recognizing anxiety in older adults and mentions effective therapies like cognitive behavioral therapy and mindfulness as potential relief options.
Read more →-PIII
Apr 15, 2025▲ +9.4%on this newsshared move
Depression
The article discusses depression in older adults, highlighting its unique presentation compared to younger individuals. It emphasizes the importance of recognizing symptoms such as fatigue and irritability, rather than just sadness. Untreated depression can lead to serious health issues, but it is treatable through various methods. Early detection through screening is crucial for effective management.
Read more →-PIII
Apr 15, 2025▲ +12.5%on this newsshared move
Sleep Apnea
The article discusses sleep apnea, a condition characterized by interrupted breathing during sleep, particularly affecting seniors. It highlights the risks associated with sleep apnea, including its links to heart disease and daytime drowsiness. The importance of awareness and understanding of chronic health conditions is emphasized for better health management.
Read more →-PIII
Apr 15, 2025▲ +15.2%on this newsshared move
Chronic Kidney Disease
Chronic kidney disease (CKD) progressively impairs kidney function, often due to diabetes or high blood pressure. It can lead to severe complications like anemia and kidney failure if not detected early. Regular blood and urine tests are crucial for early diagnosis, as symptoms may not appear until significant damage has occurred. Understanding CKD is essential for managing health, especially in seniors.
Read more →-PIII
Apr 15, 2025▲ +11.8%on this newsshared move
Arthritis
The article discusses arthritis in seniors, focusing on osteoarthritis and rheumatoid arthritis. It highlights how arthritis can hinder daily activities and increase fall risk. However, it emphasizes the importance of staying active and using assistive devices to manage pain and improve mobility. Understanding chronic health conditions is crucial for better health management.
Read more →-PIII
Apr 15, 2025▲ +8.9%on this newsshared move
Alzheimer’s Disease
Alzheimer's disease is the most prevalent form of dementia, gradually impairing memory and cognitive functions. It affects over 6 million Americans, with projections indicating this number will double by 2050. While there is no cure, early diagnosis and support can enhance the quality of life for those affected and their families.
Read more →-PIII
Apr 15, 2025▲ +8.9%on this newsshared move
Chronic Obstructive Pulmonary Disease
Chronic obstructive pulmonary disease (COPD) encompasses chronic bronchitis and emphysema, leading to breathing difficulties. It is primarily caused by long-term irritant exposure, such as cigarette smoke. Although there is no cure, symptoms can be managed through various therapies and lifestyle changes. Awareness and proactive management are essential for those affected.
Read more →-PIII
Apr 15, 2025▲ +8.9%on this newsshared move
Obesity
The article discusses the health risks associated with obesity in seniors and emphasizes the importance of weight management. It highlights that obesity can lead to various chronic conditions, affecting seniors' mobility and independence. Even modest weight loss can yield significant health benefits, encouraging seniors to take proactive steps toward better health.
Read more →-PIII
Apr 15, 2025▲ +8.9%on this newsshared move
Osteoporosis
The article discusses osteoporosis, a condition characterized by weak and fragile bones, particularly affecting older adults, especially postmenopausal women. It highlights the risks associated with osteoporosis, such as hip fractures, and emphasizes the importance of early diagnosis and proactive measures to manage bone health. Engaging in weight-bearing exercises is recommended to strengthen bones.
Read more →-PIII
Apr 15, 2025▲ +8.9%on this newsshared move
High Cholesterol
The article discusses high cholesterol, particularly in seniors, emphasizing its risks and the importance of prevention. It highlights that high cholesterol can lead to serious cardiovascular issues but often has no symptoms. Routine screening is crucial for seniors, especially those with risk factors. Dietary changes can also aid in managing cholesterol levels.
Read more →-PIII
Apr 10, 2025Type 2 Diabetes
The article discusses the impact of type 2 diabetes on senior health, highlighting its gradual onset and potential complications if left unmanaged. It emphasizes the importance of early detection and adopting healthy habits, such as mindful eating and regular physical activity, to manage the condition effectively. The article also notes that even modest weight loss can significantly reduce diabetes risk.
Read more →-PIII
Apr 10, 2025Atrial Fibrillation
Atrial fibrillation (AFib) is a common heart condition in seniors, characterized by an irregular heartbeat. It poses a significant risk for strokes, especially in those over 65. However, with appropriate medications and lifestyle changes, many individuals can manage AFib effectively. Early detection through pulse checks is crucial for preventing serious complications.
Read more →-PIII
Apr 10, 2025Congestive Heart Failure
The article discusses managing congestive heart failure (CHF) in seniors, emphasizing that CHF indicates inefficient heart pumping rather than a complete stop. It highlights common symptoms like fatigue and shortness of breath, and stresses the importance of early diagnosis and lifestyle changes. With appropriate management, many seniors can improve their heart function and quality of life.
Read more →-PIII
Apr 10, 2025▼ -7%on this newsshared move
Coronary Artery Disease
Coronary artery disease (CAD) is a condition where plaque builds up in the coronary arteries, leading to reduced blood flow to the heart. It is the leading cause of death globally but can be managed effectively through lifestyle changes and medical interventions. Regular physical activity, such as brisk walking, can significantly lower the risk of CAD.
Read more →-PIII
Apr 10, 2025▼ -7%on this newsshared move
High Blood Pressure
Hypertension, or high blood pressure, is a prevalent condition among seniors, often without symptoms. Regular checks are crucial for early detection and management. Lifestyle changes and medications can effectively control blood pressure, preventing serious health issues like stroke and heart attack. Awareness is key to better health outcomes.
Read more →-PIII
Mar 27, 2025P3 Health Partners Announces Fourth Quarter and Full Year 2024 Results Revenue increased 18% year-over-year to $1.50 billion Affirming 2025 guidance Management to Host Conference Call and Webcast
P3 Health Partners reported its financial results for the fourth quarter and full year of 2024, highlighting an 18% increase in revenue to $1.50 billion. The company's at-risk membership also grew by approximately 14%, indicating positive market engagement. However, challenges persisted with a net loss that broadened significantly compared to the previous year. Despite these hurdles, management is optimistic, affirming guidance for 2025, suggesting plans for continued growth and financial sustainability.
Read more →-PIII
Feb 13, 2025▲ +17.7%on this news
P3 Health Partners Provides Preliminary 2025 Guidance and Announces Proposed Financing Transaction Company provides preliminary 2025 guidance and advance notification of a proposed financing transaction to provide a $30
P3 Health Partners has released preliminary guidance for 2025, predicting revenues between $1.35 billion and $1.5 billion and Adjusted EBITDA of negative $35 million to $5 million. The company is pursuing a financing transaction with its largest shareholder to secure $30 million, aiming to bolster liquidity. Despite anticipated progress towards profitability, the company acknowledges significant operational risks that could affect its financial results. A definitive 2025 guidance will follow the fourth quarter 2024 earnings report.
Read more →-PIII
Dec 20, 2024Things to Do to Avoid the Holiday Blues
The article provides guidance on how to navigate the holiday season while prioritizing health and well-being. It encourages individuals to adapt traditions that no longer serve them and offers practical tips for managing holiday stress. Suggestions include maintaining health through preventive measures, creating meaningful connections, and setting intentions for the new year. Overall, it emphasizes celebrating in a way that feels right for each individual.
Read more →-PIII
Nov 12, 2024P3 Health Partners Announces Third Quarter 2024 Results Revenue increased 26% year-over-year to $362.1 million Third quarter results were affected by lower risk adjustments, higher medical expenses in the current year, a
P3 Health Partners announced a 26% increase in revenue for the third quarter of 2024, reaching $362.1 million. Despite this growth, the company faced significant challenges including higher medical expenses and a net loss of $102.9 million. Management is pursuing strategic initiatives to enhance profitability but has withdrawn its previous financial guidance due to adverse conditions. A conference call is scheduled for November 12, 2024, to discuss these results further.
Read more →-PIII
Sep 24, 2024Breast Cancer Awareness
The article emphasizes the importance of breast cancer awareness, focusing on risks, symptoms, and early detection through routine screenings. It highlights that breast cancer is the most common cancer among American women and stresses the effectiveness of mammograms in identifying the disease early. Women aged 40 and older are encouraged to discuss screening options with their healthcare providers.
Read more →-PIII
Sep 23, 2024▼ -9.4%on this newsshared move
Mental Health of Older Adults
The article discusses the mental health challenges faced by older adults, highlighting that over 20% of seniors experience mental disorders. It emphasizes the importance of recognizing signs of mental distress and provides resources for support. The article also outlines healthy habits that can improve mental well-being and encourages regular screenings for depression.
Read more →-PIII
Sep 19, 2024Fall Prevention
The article discusses the prevalence of falls among older adults, with a staggering statistic from the CDC indicating that one adult over 65 falls every second in the U.S. It outlines various risk factors contributing to falls, such as balance issues, vision and hearing loss, medication side effects, and home safety hazards. Preventative measures are suggested, including exercises, regular health check-ups, and home modifications to enhance safety.
Read more →-PIII
Sep 16, 2024Seven Tips for Healthy Aging
The article outlines seven essential tips for healthy aging, focusing on daily choices that impact well-being. Key recommendations include staying active, boosting brain health through cognitive challenges, maintaining a nutritious diet, and keeping up with vaccinations. It emphasizes the importance of preventive screenings and planning for future healthcare decisions. Managing medications effectively is also highlighted as crucial for optimal health.
Read more →-PIII
Aug 22, 2024▼ -5.9%on this news
Adult Vaccinations
The article emphasizes the importance of vaccinations for adults, particularly older adults, to protect against serious diseases. It details various recommended vaccines, including the flu shot, shingles vaccine (Shingrix), pneumonia vaccines (Prevnar 13 and 23), and the DTaP vaccine. Each vaccine's benefits, recommendations, and specific considerations are discussed to encourage adults to prioritize their health.
Read more →-PIII
Aug 7, 2024P3 Health Partners Announces Second Quarter 2024 Results Management to Host Conference Call and Webcast
P3 Health Partners reported its financial results for the second quarter of 2024, noting a 15% increase in total revenue to $379.2 million. Despite the revenue growth, the company faced challenges such as a drop in gross profit and an increase in net loss compared to the previous year. CEO Aric Coffman highlighted ongoing initiatives aimed at enhancing capabilities for sustainable profitability. The company also issued guidance for the remainder of the fiscal year.
Read more →-PIII
May 8, 2024P3 Health Partners Announces First Quarter 2024 Results Dr. Aric Coffman joins P3 Health Partners as CEO Total revenue growth of 29% year-over-year Reaffirming 2024 guidance Anticipates reaching Adjusted EBITDA positive
P3 Health Partners has reported a robust 29% increase in total revenue for Q1 2024 compared to the same period last year. The company's newly appointed CEO, Dr. Aric Coffman, emphasized the potential for sustainable value creation and profitability. Despite the strong revenue growth, P3 experienced a net loss of $49.6 million, although this was an improvement from the prior year's loss. The company reaffirmed its optimistic guidance for the remainder of 2024.
Read more →-PIII
Apr 11, 2024Make the Most Out of Your Healthcare Visit
The article outlines strategies to maximize the efficiency of healthcare visits. It emphasizes the importance of preparation, including gathering necessary documents and prioritizing questions. The article also highlights the value of open communication with healthcare providers and encourages patients to actively engage in their health decisions.
Read more →-PIII
Apr 10, 2024▼ -10.9%on this news· ran to -30% by day 3shared move
Call Your Primary Care Provider First
The article emphasizes the importance of contacting your primary care provider when feeling unwell, rather than heading directly to the emergency room. It outlines the benefits of establishing a relationship with a provider and suggests urgent care as a viable option for non-life-threatening conditions. The piece also provides contact information for care management teams in various states.
Read more →-PIII
Apr 10, 2024▼ -10.9%on this news· ran to -30% by day 3shared move
Four Things to Know About an Annual Wellness Exam
The article emphasizes the significance of scheduling an annual wellness exam to maintain health. It outlines what to expect during the visit, including health assessments and goal setting. The piece advocates for proactive health management and early detection of potential issues, making it a crucial aspect of personal healthcare.
Read more →-PIII
Apr 1, 2024▼ -14.1%on this news
Tips for Managing Seasonal Allergies, Asthma and COPD
The article offers guidance on managing seasonal allergies, asthma, and COPD. It emphasizes the importance of identifying allergens, using protective measures, and consulting healthcare providers. The piece outlines specific strategies for minimizing exposure and managing symptoms effectively, particularly for individuals with chronic respiratory conditions. Overall, it encourages proactive health management during allergy season.
Read more →-PIII
Mar 28, 2024P3 Health Partners Announces Fourth Quarter and Full Year 2023 Results Total revenue growth of 21% year-over-year, beating our 2023 guidance Affirming 2024 guidance Anticipates reaching Adjusted EBITDA positive in 2024 M
P3 Health Partners reported a strong financial performance for the fourth quarter and full year 2023, achieving a total revenue of $1.27 billion, representing a 21% growth from the previous year. The company affirmed its 2024 guidance, projecting continued growth in revenue and membership. Despite posting a net loss of $69.1 million in Q4, improvements in gross profit and medical margins were noted. The firm anticipates becoming Adjusted EBITDA positive in 2024, suggesting a positive outlook for its operational growth.
Read more →-PIII
Mar 10, 2024▼ -5.5%on this news· ran to -36% by day 3
Elevate Your Well-being: Transformative Nutrition Tips for National Nutrition Month
The article highlights National Nutrition Month, emphasizing the importance of making informed food choices and developing healthy habits. It outlines six practical steps to improve nutrition, including cooking at home, controlling portion sizes, and incorporating a variety of food groups. The piece also encourages physical activity and consulting with healthcare providers for personalized meal planning.
Read more →-PIII
Feb 28, 2024Lifestyle Changes and Blood Pressure
The article discusses the importance of lifestyle changes in managing high blood pressure, also known as hypertension. It highlights dietary modifications, weight management through regular exercise, and quitting smoking as effective strategies. While these changes can greatly improve blood pressure control, some individuals may still need medication. The article encourages readers to consult healthcare providers for tailored care plans.
Read more →-PIII
Feb 15, 2024Understanding Blood Pressure
The article discusses high blood pressure, also known as hypertension, which affects nearly 50% of the US population. It highlights the health risks associated with untreated hypertension, including heart disease and stroke. The article emphasizes the importance of regular monitoring, lifestyle changes, and potential medication for managing blood pressure effectively.
Read more →-PIII
Jan 18, 2024Exercising for Older Adults
The article emphasizes the importance of exercise for older adults, highlighting its numerous health benefits, including reduced risks of heart disease and improved cognitive function. It outlines recommended types of exercises, such as strength training and yoga, and suggests a minimum of 150 minutes of moderate exercise weekly. The piece encourages seniors to consult healthcare providers before starting any exercise regimen.
Read more →-PIII
Jan 9, 2024Document P3 Health Partners Reaffirms Guidance for 2023 and Announces Guidance for 2024 Henderson, NV
P3 Health Partners Inc. has reaffirmed its guidance for 2023 and provided new guidance for 2024 during the J.P. Morgan Healthcare Conference. The company anticipates achieving meaningful profitability in 2024, with projected revenue growth from $1.45 billion to $1.55 billion. Additionally, they expect to increase their Medicare Advantage Members and improve their medical margins. The leadership emphasizes a robust pipeline of strategic partnerships as a driving force for growth.
Read more →-PIII
Nov 20, 2023Tough Talks Over Turkey
The article discusses the importance of having proactive conversations with aging parents about long-term care. It provides practical tips for approaching these sensitive discussions, including preparation, consideration, and listening to their needs. By fostering open communication, families can better navigate the complexities of aging and care preferences.
Read more →-PIII
Nov 20, 2023Tips for a Healthy Thanksgiving
The article offers tips for maintaining a healthy lifestyle during Thanksgiving, emphasizing the importance of not skipping breakfast, exercising, and practicing portion control. It suggests revamping traditional dishes for healthier options and encourages mindful eating. Additionally, it advises limiting alcohol consumption and focusing on family connections during the holiday season.
Read more →-PIII
Nov 9, 2023▲ +6.1%on this news
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM To the Stockholders and Board of Directors of P3 Health Partners Inc. (f/k/a Foresight Acquisition Corp.) Opinion on the Financial Statements We have audited the ac
P3 Health Partners Inc. has reported its financial statements audited for the periods ending December 2, 2021, and December 31, 2020. The reports highlight a significant net loss and raise concerns about the company's viability as a going concern, primarily due to insufficient cash and working capital. The financial condition is compounded by the need for a successful business combination for future operations. The auditors highlighted that the financial statements reflect these substantial uncertainties.
Read more →-PIII
Nov 8, 2023▼ -7.7%on this newsshared move
Document P3 Health Partners Announces Third-Quarter and Year-to-Date 2023 Results YTD total revenue growth of 16% Continued strong performance across markets, re-affirming 2023 guidance Provides preliminary 2024 Full-Yea
P3 Health Partners reported its financial results for the third quarter of 2023, demonstrating a year-to-date total revenue growth of 16% compared to the previous year. The company reaffirmed its guidance for 2023 and provided preliminary guidance for 2024, forecasting an Adjusted EBITDA of $20 million to $40 million. Despite the positive revenue growth, the company experienced an increase in net loss, which heightened by 43% year-over-year, while the gross profit improved significantly. The management will hold a conference call to discuss these results on November 8, 2023.
Read more →-PIII
Nov 3, 2023P3 Health Partners Schedules Third-Quarter 2023 Earnings Release and Conference Call
P3 Health Partners Inc. will release its third-quarter 2023 financial results on November 8, 2023. The company will host a conference call and webcast at 4:30 PM ET to discuss the results and provide updates. Interested parties can join the call via toll-free numbers or through the company's investor webpage.
Read more →-PIII
Sep 5, 2023▼ -7.1%on this news
P3 Health Partners to Participate in the Lake Street Best Ideas Growth Conference
P3 Health Partners Inc. will participate in the Lake Street Best Ideas Growth Conference on September 14, 2023, in New York. The company focuses on population health management and aims to enhance patient care through value-based services. With over 2,600 affiliated providers, P3 is dedicated to improving healthcare outcomes across multiple states.
Read more →-PIII
Aug 29, 2023▲ +23.4%on this news· ran to +50% by day 3
P3 Health Partners to Present at Wells Fargo Healthcare Conference
P3 Health Partners Inc. will present at the Wells Fargo Healthcare Conference on September 7, 2023. The event will take place in Boston, Massachusetts, and a live webcast will be available. P3 Health Partners is dedicated to enhancing healthcare through a network of primary care providers and value-based care coordination.
Read more →-PIII
Aug 21, 2023Tips and Resources for Caregivers
The article offers essential tips and resources for caregivers, emphasizing the importance of self-care and support. It highlights the emotional challenges faced by caregivers and suggests practical strategies such as asking for help, taking breaks, and prioritizing health. The article also encourages caregivers to maintain connections with loved ones and plan for future care needs.
Read more →-PIII
Aug 7, 2023P3 Health Partners Announces Second-Quarter 2023 Results
P3 Health Partners reported its second-quarter 2023 financial results, showing significant improvements across key metrics. Capitated revenue rose 21.9% year-over-year, while net loss decreased dramatically from $903.1 million to $27.6 million. The company also noted a substantial increase in medical margin and a reduction in adjusted EBITDA loss, indicating a positive trajectory for future growth.
Read more →-PIII
Aug 7, 2023Document P3 Health Partners Announces Second-Quarter 2023 Results Management to Host Conference Call and Webcast
P3 Health Partners (NASDAQ: PIII) announced solid financial results for the second quarter of 2023, highlighting a notable 21.9% increase in capitated revenue year-over-year. The company reduced its net loss to $27.6 million from a staggering $903.1 million in the same quarter last year. Key metrics indicate a successful trajectory for P3's health management model, although the company still anticipates some financial losses going forward. A conference call to discuss these results is scheduled for August 7, 2023.
Read more →-PIII
Jul 28, 2023P3 Health Partners Schedules Second-Quarter 2023 Earnings Release and Conference Call
P3 Health Partners Inc. will release its second-quarter 2023 financial results on August 7, 2023. The company will host a conference call and webcast at 4:30 PM ET to discuss the results and provide updates. P3 Health is focused on enhancing patient care through a network of primary care providers across multiple states.
Read more →-PIII
May 10, 2023▲ +8.8%on this news· ran to +49% by day 3
Document P3 Health Partners Announces First-Quarter 2023 Results - Capitated revenue increases 11% vs. the same period in the prior year - Q1 2023 operating loss improved 7% vs. the same period in the prior year - Q1 202
P3 Health Partners has reported its financial results for the first quarter of 2023, showing an 11% increase in capitated revenue year-over-year. The company has also noted a 7% improvement in operating loss and a substantial 58% rise in medical margin. Despite these positive trends, P3 Health Partners continues to face challenges with a net loss of $52.4 million. As a result of its strong quarter, the company has raised its Adjusted EBITDA guidance for the year.
Read more →-PIII
Mar 31, 2023P3 Health Partners Announces Fourth Quarter and Full-Year 2022 Results Affirming 2023 guidance - introducing year-end medical margin guidance Anticipates reaching Adjusted EBITDA positive in early 2024 Management to Host
P3 Health Partners Inc. reported its fourth quarter and full-year 2022 financial results, highlighting a 65% increase in network contributions compared to 2021. The company announced its guidance for 2023 along with the introduction of new non-GAAP financial metrics, including medical margin and network contribution. P3 expects to reach Adjusted EBITDA profitability in early 2024, supported by a solid financing deal and a strategic focus on persistent lives and reduced operating expenses. A conference call to discuss these results and future outlook will occur on March 31, 2023.
Read more →-PIII
Mar 14, 2023▼ -6%on this news
P3 Health Partners Affirms 2023 Outlook and Schedules Earnings Call for 2022 Results Henderson, Nev.
P3 Health Partners Inc. has announced its reaffirmation of the 2023 outlook and plans to file its Annual Report on Form 10-K by March 30, 2023. The delay in filing is administrative due to the late audit for 2021, affecting the schedule for the 2022 financial results. Company leadership remains optimistic about meeting previously disclosed financial goals despite these challenges.
Read more →-PIII
Jan 11, 2023P3 Health Partners Reaffirms Guidance For 2022 and Announces Guidance For 2023 Henderson, Nev.
P3 Health Partners Inc. has reaffirmed its full-year 2022 financial guidance and announced its guidance for 2023 during the J.P. Morgan Healthcare Conference. The company's CEO is scheduled to present information relevant to their financial outlook. P3 Health Partners emphasizes its commitment to improving healthcare outcomes through its expansive network of primary care providers. Their announcements reflect confidence in the sustainability of their operational growth and management strategies.
Read more →-PIII
Nov 14, 2022P3 Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial Results Strong Third-Quarter YTD 2022 revenue growth of 59% compared to the Third-Quarter YTD 2021 At-risk Medicare Advantage members exceeded 101
Health Partners Provides Third-Quarter and Year-to-Date 2022 Financial Results 2022 4:15 PM Eastern Standard Time Nev.--(BUSINESS WIRE)--P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company,
Read more →-PIII
Oct 20, 2022P3 Health Partners Provides Second-Quarter and Year-to-Date 2022 Financial Results Increases 2022 Revenue Outlook Strong First-Half 2022 revenue growth of 84% compared to the First-Half 2021 At-risk Medicare Advantage me
Provides Second-Quarter and Year-to-Date 2022 Increases 2022 Revenue Outlook NV, October 20, 2022 (BUSINESS WIRE) -- P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today announced its
Read more →-PIII
Oct 4, 2022P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company's Securities The Company Intends to
P3 Health Partners Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company's Securities The Company Intends to Submit All Periodic Reports and Hold an Earnings Call
Read more →-PIII
Aug 19, 2022P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report Henderson, NV
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Report NV, August 19, 2022 (GLOBE NEWSWIRE) -P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management company, today
Read more →-PIII
May 24, 2022P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports Henderson, NV
P3 Health Partners Announces Receipt of Nasdaq Notice Regarding Late Filing of Periodic Reports Henderson, NV, May 24, 2022 (GLOBE NEWSWIRE) -- P3 Health Partners Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physician-led population health management co
Read more →-PIII
Apr 14, 2022P3 Health Partners to Present Fourth Quarter and Full Year 2021 Financial Results Management to Host Conference Call and Webcast
P3 Health Partners to Present Fourth Quarter and Full Year 2021 Financial Results Management to Host Conference Call and Webcast April 25, 2022 at 4:30 PM ET NV, April 14, 2022 - P3 Health Partners, Inc. ("P3" or the "Company") (NASDAQ: PIII), a patient-centered and physicia
Read more →-PIII
Mar 9, 2022P3 Health Partners Announces Select Preliminary Fourth Quarter and Full Year 2021 Results, and Introduces 2022 Outlook Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue
P3 Health Partners Announces Select Preliminary Full Year 2021 Results, and Introduces 2022 Outlook Strong revenue growth of 46% for the fourth quarter and 32% for full year 2021 Full year 2022 revenue expected to be up to $1 billion, a 56% increase vs. prior year At-risk M
Read more →-PIII
Dec 28, 2021Who: People with Passion and Purpose What: Dedicated to Transforming Healthcare for Patients, Providers, and Payors How: Patient-Centric, Physician-Led, and Population Health Management Focused J.P. Morgan Healthcare Con
Value-Based Care Physician Enablers1 ~68k ~210k ~109k ~85k ~31k ~26k % of Total Medicare Advantage Enrollment2 ~2% of ~24mm MA enrollees 9 Proven Outcomes And Physician-Led We are able to drive enhanced outcomes via our patient- centric, physician-led care model: 35% / 36% Reduct
Read more →-PIII
Dec 9, 2021P3 HEALTH GROUP HOLDINGS, LLC and SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2021 and 2020 1 P3 HEALTH GROUP HOLDINGS, LLC and SUBSIDIARIES COND
HOLDINGS, LLC and SUBSIDIARIES CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AND NINE MONTHS ENDED SEPTEMBER 30, 2021 and 2020 HOLDINGS, LLC and SUBSIDIARIES CONDENSED CONSOLIDATED ASSETS Unaudited September 30, 2021 December 31, 2020 CURRENT ASSETS:
Read more →-PIII
Sep 22, 2021P3 Analyst Day Presentation September 2021 Who: People with Passion and Purpose What: Dedicated to Transforming Healthcare for Patients, Providers, and Payors How: Patient-Centric, Physician-Led, and Population Health Ma
Passion and Purpose What: Dedicated to Transforming Healthcare for Patients, Providers, and Payors How: Patient-Centric, Physician-Led, and Population Health Management FocusedExhibit 99.1 P3 Analyst Day Presentation September 2021 Who: People with Passion and Purpose What: Dedi
Read more →-PIII
May 25, 2021P3 Health Partners to Become Publicly Traded via Merger with Foresight Acquisition Corp. - Transaction to Publicly List P3 Health Partners, a Patient-Centered and Physician-Led Population Health Management Company Delive
P3 Health Partners to Become Publicly Traded via Merger with Foresight Acquisition Corp. - Transaction to Publicly List P3 Health Partners, a Patient-Centered and Physician-Led Population Health Management Company Delivering Value-Based Care - Estimated Post-Transaction Enterp
Read more →-PIII
Feb 12, 2021INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of Foresight Acquisition Corp.: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of
INDEX TO FINANCIAL STATEMENT Page Audited Financial Statement of Foresight Acquisition Corp.: Report of Independent Registered Public Accounting Firm F-2 Balance Sheet as of February 12, 2021 F-3 Notes to Financial Statement F-4 REPORT OF INDEPENDENT REGISTERED
Read more →-PIII
Feb 10, 2021Foresight Acquisition Corp. Announces Pricing of $275,000,000 Initial Public Offering Foresight Acquisition Corp. (the Company ), a blank check company targeting a technology-enabled consumer or consumer healthcare busin
Foresight Acquisition Corp. Announces Pricing of $275,000,000 Initial Public Offering Foresight Acquisition Corp. (the Company ), a blank check company targeting a technology-enabled consumer or consumer healthcare business, announced today the pricing of its initial public off
Read more →Competitive Position
How PIII ranks across every disease it competes inCompetitive Position is a premium feature
See how PIII ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial